Related Experiment Video

Updated: Nov 25, 2025

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
03:53

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses

Published on: November 10, 2023

1.6K

Clinical Spectrum of COVID-19 in a Mexican Pediatric Population

Edgar Bustos-Cordova1, Daniela Castillo-Garcia2, Magdalena Ceron-Rodriguez1

  • 1Emergency Department, Hospital Infantil de México Federico Gómez, Mexico.

Indian Pediatrics
|December 19, 2020
PubMed

Insights

The clinical spectrum of coronavirus disease 2019 (COVID-19) in children is broader than previously understood. Digestive symptoms, fever, and irritability are common indicators in pediatric COVID-19 cases.

Area of Science:

  • Pediatric Infectious Diseases
  • Viral Respiratory Illnesses

Background:

  • Coronavirus disease 2019 (COVID-19) presents unique challenges in pediatric populations.
  • Understanding the full clinical spectrum in children is crucial for timely diagnosis and management.

Purpose of the Study:

  • To describe the broader clinical spectrum of COVID-19 in children.
  • To identify common symptoms and signs associated with pediatric COVID-19.

Main Methods:

  • A descriptive, prospective study was conducted.
  • Confirmed pediatric COVID-19 patients presenting to a tertiary care emergency department were analyzed.
  • Data included 24 symptoms and 25 signs from 50 patients.

Main Results:

  • Fever, excessive crying, and dry cough were the most frequent symptoms.
  • Digestive symptoms were present in 24% of cases.
  • Pharyngeal erythema and irritability were the most common signs.

Conclusions:

  • The clinical presentation of COVID-19 in children is diverse and often nonspecific.
  • Digestive symptoms in pediatric patients warrant suspicion for COVID-19.
  • Clinicians must consider a wider range of symptoms and signs for accurate diagnosis.
Abstract

More Related Videos

Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis08:44

Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis

Published on: September 7, 2022

2.7K
Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic09:03

Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic

Published on: November 7, 2020

5.2K

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
134
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
109
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
90
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
110
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.6K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
1.9K